Filtered By:
Countries: France Health

This page shows you your search results in order of relevance. This is page number 2.

Order by Relevance | Date

Total 729 results found since Jan 2013.

The inter-rater reliability of the Turkish version of Aphasia Rapid Test for stroke
Conclusions: Findings indicate that the Turkish version of the original ART was successfully administered in Turkish-speaking patients.PMID:34060434 | DOI:10.1080/10749357.2021.1923314
Source: Topics in Stroke Rehabilitation - June 1, 2021 Category: Neurology Authors: Mariam Kavakci Engin Koyuncu Melike Tanriverdi Emre Adiguzel Evren Yasar Source Type: research

More Than 50 Percent Reduction in LDL Cholesterol in Patients With Target LDL & lt;70 mg/dL After a Stroke
CONCLUSIONS: In this post hoc analysis of the TST trial, targeting an LDL cholesterol of <70 mg/dL reduced the risk of primary outcome compared with 100±10 mg/dL provided LDL cholesterol reduction from baseline was superior to 50%, thereby suggesting that the magnitude of LDL cholesterol reduction was as important to consider as the target level to achieve.REGISTRATION: URL: https://www.CLINICALTRIALS: gov; Unique identifier: NCT01252875; https://clinicaltrialsregister.eu; Unique identifier: EUDRACT2009-A01280-57.PMID:37376989 | DOI:10.1161/STROKEAHA.123.042621
Source: Atherosclerosis - June 28, 2023 Category: Cardiology Authors: Pierre Amarenco Philippa C Lavall ée Jong S Kim Julien Labreuche Hugo Charles Maurice Giroud Byung-Chul Lee Marie-H élène Mahagne Elena Meseguer Norbert Nighoghossian Philippe Gabriel Steg Éric Vicaut Eric Bruckert Treat Stroke to Target Investigators Source Type: research

Certain gut microbes may affect stroke risk and severity, scientists find
Studies of ischaemic stroke patients open up possibility of treatments to prevent condition and improve recoveryScientists have identified specific groups of gut microbes that could increase or decrease someone ’s risk of suffering the most common type of stroke. The research, presented at the European Stroke Organisation Conference (ESOC) in Lyon, France, adds to growing evidence that alterations in the gut microbiome could play a role in cardiovascular disease.Previous studies have suggested that certain microbes may influence the formation of atherosclerotic plaques in the arteries, and that the gut microbiomes of str...
Source: Guardian Unlimited Science - May 4, 2022 Category: Science Authors: Linda Geddes Science correspondent Tags: Stroke Biology Science Microbiology Health Medical research Source Type: news

Intravenous Recombinant Tissue-Type Plasminogen Activator Clinical Sciences
Conclusions—In this population, previous IVT improved functional outcome and survival at 3 months in patients treated by MT. While waiting for randomized controlled trials, this result encourages not to avoid IVT before MT.
Source: Stroke - May 25, 2018 Category: Neurology Authors: Marc Ferrigno, Nicolas Bricout, Didier Leys, Laurent Estrade, Charlotte Cordonnier, Thomas Personnic, Maeva Kyheng, Hilde Henon Tags: Cerebrovascular Disease/Stroke, Ischemic Stroke Original Contributions Source Type: research

Endovascular reperfusion of M2 occlusions in acute ischemic stroke reduced disability and mortality: ETIS Registry results
Conclusions Successful reperfusion of M2 occlusions reduced disability and mortality. However, safety is a concern, especially if the procedure failed.
Source: Journal of NeuroInterventional Surgery - April 12, 2022 Category: Neurosurgery Authors: Muszynski, P., Anadani, M., Richard, S., Marnat, G., Bourcier, R., Sibon, I., Dargazanli, C., Arquizan, C., Maïer, B., Blanc, R., Lapergue, B., Consoli, A., Eugene, F., Vannier, S., Spelle, L., Denier, C., Boulanger, M., Gauberti, M., Saleme, S., Tags: Ischemic stroke Source Type: research

Early Hyperchloremia and Outcomes After Acute Ischemic Stroke
There may be a potential relationship between hyperchloremia and death or disability after ischemic stroke given the association between hyperchloremia and acute kidney injury (AKI)1,2 and increased risk of death or disability with AKI.3 –5 Huang et al.6 reported that approximately 18% of patients with stroke have new onset hyperchloremia (≥ 110 mmol/L) within 72 h of admission which was associated with death or disability at 6 months. However, the association was no longer significant after adjusting for age and National In stitutes of Health stroke scale (NIHSS) scores.
Source: Journal of Stroke and Cerebrovascular Diseases - May 25, 2022 Category: Neurology Authors: Adnan I. Qureshi, Wei Huang, Francisco E. Gomez, Kunal Malhotra, Niraj Arora, Premkumar N. Chandrasekaran, Farhan Siddiq, Brandi R. French, Camilo R. Gomez, Jose I. Suarez Source Type: research

Preprocedure Intravenous Recombinant Tissue Plasminogen Activator and Risk of Distal Embolization with Thrombectomy in Acute Ischemic Stroke
Background: Intravenous recombinant tissue plasminogen activator (IV rt-PA) prior to thrombectomy may reduce the risk of intraprocedural distal embolization in acute ischemic stroke patients. Methods: We analyzed the diffusion-weighted imaging acquired with 1.5- or 3-T magnetic resonance imaging (MRI) scans obtained within 24 hours of thrombectomy in consecutive acute ischemic stroke patients. An independent physician identified distal embolization, defined as discrete foci of restricted diffusion independent of the primary area of infarction on MRI scan.
Source: Journal of Stroke and Cerebrovascular Diseases - September 23, 2019 Category: Neurology Authors: Adnan I. Qureshi, Ahmer Asif, Emrah Aytac, Jahanzeb Liaqat, Erdem Gurkas, Iryna Lobanova, Omar Saeed, Humera Ahsan, Farhan Siddiq, Camilo R. Gomez, Brandi R. French Source Type: research

Effect of COVID-19 Pandemic on Mechanical Thrombectomy for Acute Ischemic Stroke Treatment in United States
There is accumulating data suggesting that the ischemic stroke may be increased in patients with corona virus disease 2019 (COVID-19) due to hyper coagulopathy1,2. An increase in acute ischemic stroke patients who require mechanical thrombectomy is to be expected particularly in regions with high rates of COVID-191.
Source: Journal of Stroke and Cerebrovascular Diseases - July 10, 2020 Category: Neurology Authors: Adnan Qureshi, Farhan Siddiq, Brandi French, Camilo Gomez, Vishal Jani, Ameer Hassan, Muhammad Fareed Suri Source Type: research

Utilization and Outcomes of Acute Revascularization Treatment in Ischemic Stroke Patients with SARS-CoV-2 Infection
Our understanding of outcomes in acute ischemic stroke patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection following acute revascularization treatments (as intravenous thrombolysis and/or thrombectomy) is based on small case series.1-3. An international panel4 cautioned regarding the potential for high rate of death or disability and post thrombolytic intracerebral hemorrhage (ICH)s in acute ischemic stroke patients with SARS-CoV-2 infection due to elevated concentrations of inflammation and hypercoagulability markers such as leukocytosis, and C reactive protein and D dimers and multisystem dysfunction.
Source: Journal of Stroke and Cerebrovascular Diseases - October 7, 2021 Category: Neurology Authors: Adnan I. Qureshi, William I. Baskett, Wei Huang, Muhammad F. Ishfaq, S. Hasan Naqvi, Brandi R. French, Farhan Siddiq, Camilo R. Gomez, Chi-Ren Shyu Tags: SARS-CoV-2 and acute revascularization Source Type: research

Utilization and Outcomes of Acute Revascularization Treatments in Ischemic Stroke Patients with SARS-CoV-2 Infection
Our understanding of outcomes in acute ischemic stroke patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection following acute revascularization treatments (as intravenous thrombolysis and/or thrombectomy) is based on small case series.1 –3 An international panel4 cautioned regarding the potential for high rate of death or disability and post thrombolytic intracerebral hemorrhage (ICH)s in acute ischemic stroke patients with SARS-CoV-2 infection due to elevated concentrations of inflammation and hypercoagulability markers such as leukocytosis, and C reactive protein and D dimers and multisystem dysfunction.
Source: Journal of Stroke and Cerebrovascular Diseases - October 7, 2021 Category: Neurology Authors: Adnan I. Qureshi, William I. Baskett, Wei Huang, Muhammad F. Ishfaq, S. Hasan Naqvi, Brandi R. French, Farhan Siddiq, Camilo R. Gomez, Chi-Ren Shyu Source Type: research

Annual Direct Cost of Dysphagia Associated with Acute Ischemic Stroke in the United States
Dysphagia after acute ischemic stroke is frequent and increases the risk of pneumonia, insertion of feeding tube, hospital length-of-stay and rates of discharge to institutional care. However, the financial impact of dysphagia after acute ischemic stroke is not well understood.
Source: Journal of Stroke and Cerebrovascular Diseases - March 5, 2022 Category: Neurology Authors: Adnan I. Qureshi, M. Fareed K. Suri, Wei Huang, Yasemin Akinci, Mohammad R. Chaudhry, Donna S. Pond, Brandi R. French, Farhan Siddiq, Camilo R. Gomez Source Type: research